课题基金 / 基金详情

Tfh and B cells in HIV/SIV pathogenesis and vaccination

Tfh and B cells in HIV/SIV pathogenesis and vaccination
Tfh 和 B 细胞在 HIV/SIV 发病机制和疫苗接种中的作用
批准号:
9161747
负责人:
Richard A Koup
金额:
$127.39万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Richard A Koup的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mouse, non-human primate (NHP) and human Tfh cells share phenotypic, functional and molecular programs which are regulated by local signals and spatiotemporal factors. Chronic HIV/SIV infection results in accumulation of Tfh, germinal center (GC) B cells and circulating virus-specific immunoglobulins in some subjects. However, most HIV/SIV infected subjects do not mount broadly neutralizing antibodies, pointing to functional defects in Tfh cells in chronic HIV/SIV infection. The susceptibility of particular CD4 T cells populations to HIV/SIV infection within lymph nodes notably impacts upon the dynamics of Tfh-GC B cell interactions. Some circulating CD4 T cells share certain characteristics with Tfh cells, however their direct origin from GC Tfh cells is not clear. There are many ways in which HIV and SIV influence the complex signals and mechanisms regulating the development of Tfh cells and their interactions with GC B cells. Understanding the biology of Tfh cells will be necessary to appropriately recruit these cells during vaccination with the goal of stimulating a more broad and potent neutralizing antibody response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tfh and B cells in HIV/SIV pathogenesis and vaccination
Immune Reconstitution
Tfh and B cells in HIV/SIV pathogenesis and vaccination
Pre-clinical Vaccine Development for Respiratory Viruses
海外基金